Rockwell Medical Inc (RMTI)
1.46
-0.02
(-1.35%)
USD |
NASDAQ |
Apr 19, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
Rockwell Medical Price to Book Value: 2.012 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 2.039 |
| April 17, 2024 | 2.039 |
| April 16, 2024 | 2.053 |
| April 15, 2024 | 2.101 |
| April 12, 2024 | 2.204 |
| April 11, 2024 | 2.232 |
| April 10, 2024 | 2.177 |
| April 09, 2024 | 2.232 |
| April 08, 2024 | 2.232 |
| April 05, 2024 | 2.273 |
| April 04, 2024 | 2.328 |
| April 03, 2024 | 2.246 |
| April 02, 2024 | 2.287 |
| April 01, 2024 | 2.342 |
| March 28, 2024 | 2.287 |
| March 27, 2024 | 2.260 |
| March 26, 2024 | 2.273 |
| March 25, 2024 | 2.232 |
| March 22, 2024 | 2.356 |
| March 21, 2024 | 2.094 |
| March 20, 2024 | 2.258 |
| March 19, 2024 | 1.929 |
| March 18, 2024 | 1.902 |
| March 15, 2024 | 1.916 |
| March 14, 2024 | 1.902 |
| Date | Value |
|---|---|
| March 13, 2024 | 1.998 |
| March 12, 2024 | 1.970 |
| March 11, 2024 | 2.107 |
| March 08, 2024 | 2.080 |
| March 07, 2024 | 2.093 |
| March 06, 2024 | 2.052 |
| March 05, 2024 | 2.025 |
| March 04, 2024 | 2.011 |
| March 01, 2024 | 2.134 |
| February 29, 2024 | 1.929 |
| February 28, 2024 | 1.861 |
| February 27, 2024 | 1.874 |
| February 26, 2024 | 1.874 |
| February 23, 2024 | 1.724 |
| February 22, 2024 | 1.765 |
| February 21, 2024 | 1.820 |
| February 20, 2024 | 1.833 |
| February 16, 2024 | 1.847 |
| February 15, 2024 | 1.902 |
| February 14, 2024 | 1.765 |
| February 13, 2024 | 1.765 |
| February 12, 2024 | 1.833 |
| February 09, 2024 | 1.779 |
| February 08, 2024 | 1.683 |
| February 07, 2024 | 1.710 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5589
Minimum
Jul 18 2022
18.87
Maximum
Jan 19 2022
5.030
Average
3.752
Median
Jan 21 2021
Price to Book Value Benchmarks
| Cyclacel Pharmaceuticals Inc | 3.909 |
| Oragenics Inc | 3.299 |
| Alpine Immune Sciences Inc | 12.89 |
| Corvus Pharmaceuticals Inc | 1.787 |
| MAIA Biotechnology Inc | 92.24 |
Price to Book Value Related Metrics
| PS Ratio | 0.4063 |
| Price | 1.46 |
| Earnings Yield | -27.40% |
| Market Cap | 42.83M |